These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 11771751

  • 1. Decreased protein levels of stathmin in adult brains with Down syndrome and Alzheimer's disease.
    Cheon MS, Fountoulakis M, Cairns NJ, Dierssen M, Herkner K, Lubec G.
    J Neural Transm Suppl; 2001; (61):281-8. PubMed ID: 11771751
    [Abstract] [Full Text] [Related]

  • 2. Decreased brain levels of 2',3'-cyclic nucleotide-3'-phosphodiesterase in Down syndrome and Alzheimer's disease.
    Vlkolinský R, Cairns N, Fountoulakis M, Lubec G.
    Neurobiol Aging; 2001; 22(4):547-53. PubMed ID: 11445254
    [Abstract] [Full Text] [Related]

  • 3. Neurofibrillary tangle-associated alteration of stathmin in Alzheimer's disease.
    Jin LW, Masliah E, Iimoto D, Deteresa R, Mallory M, Sundsmo M, Mori N, Sobel A, Saitoh T.
    Neurobiol Aging; 1996; 17(3):331-41. PubMed ID: 8725893
    [Abstract] [Full Text] [Related]

  • 4. Heart type fatty acid binding protein (H-FABP) is decreased in brains of patients with Down syndrome and Alzheimer's disease.
    Cheon MS, Kim SH, Fountoulakis M, Lubec G.
    J Neural Transm Suppl; 2003; (67):225-34. PubMed ID: 15068254
    [Abstract] [Full Text] [Related]

  • 5. Decreased brain histamine-releasing factor protein in patients with Down syndrome and Alzheimer's disease.
    Kim SH, Cairns N, Fountoulakisc M, Lubec G.
    Neurosci Lett; 2001 Mar 02; 300(1):41-4. PubMed ID: 11172935
    [Abstract] [Full Text] [Related]

  • 6. Synaptosomal proteins, beta-soluble N-ethylmaleimide-sensitive factor attachment protein (beta-SNAP), gamma-SNAP and synaptotagmin I in brain of patients with Down syndrome and Alzheimer's disease.
    Yoo BC, Cairns N, Fountoulakis M, Lubec G.
    Dement Geriatr Cogn Disord; 2001 Mar 02; 12(3):219-25. PubMed ID: 11244216
    [Abstract] [Full Text] [Related]

  • 7. Proteomic comparison between human young and old brains by two-dimensional gel electrophoresis and identification of proteins.
    Chen W, Ji J, Xu X, He S, Ru B.
    Int J Dev Neurosci; 2003 Jun 02; 21(4):209-16. PubMed ID: 12781788
    [Abstract] [Full Text] [Related]

  • 8. Changes of voltage-dependent anion-selective channel proteins VDAC1 and VDAC2 brain levels in patients with Alzheimer's disease and Down syndrome.
    Yoo BC, Fountoulakis M, Cairns N, Lubec G.
    Electrophoresis; 2001 Jan 02; 22(1):172-9. PubMed ID: 11197169
    [Abstract] [Full Text] [Related]

  • 9. Decreased protein levels of complex I 30-kDa subunit in fetal Down syndrome brains.
    Kim SH, Fountoulakis M, Dierssen M, Lubec G.
    J Neural Transm Suppl; 2001 Jan 02; (61):109-16. PubMed ID: 11771736
    [Abstract] [Full Text] [Related]

  • 10. Expression profiles of proteins in fetal brain with Down syndrome.
    Cheon MS, Fountoulakis M, Dierssen M, Ferreres JC, Lubec G.
    J Neural Transm Suppl; 2001 Jan 02; (61):311-9. PubMed ID: 11771754
    [Abstract] [Full Text] [Related]

  • 11. Increased brain protein levels of carbonyl reductase and alcohol dehydrogenase in Down syndrome and Alzheimer's disease.
    Balcz B, Kirchner L, Cairns N, Fountoulakis M, Lubec G.
    J Neural Transm Suppl; 2001 Jan 02; (61):193-201. PubMed ID: 11771743
    [Abstract] [Full Text] [Related]

  • 12. Protein levels of human peroxiredoxin subtypes in brains of patients with Alzheimer's disease and Down syndrome.
    Kim SH, Fountoulakis M, Cairns N, Lubec G.
    J Neural Transm Suppl; 2001 Jan 02; (61):223-35. PubMed ID: 11771746
    [Abstract] [Full Text] [Related]

  • 13. Unaltered expression of Fas (CD95/APO-1), caspase-3, Bcl-2 and annexins in brains of fetal Down syndrome: evidence against increased apoptosis.
    Engidawork E, Balic N, Juranville JF, Fountoulakis M, Dierssen M, Lubec G.
    J Neural Transm Suppl; 2001 Jan 02; (61):149-62. PubMed ID: 11771740
    [Abstract] [Full Text] [Related]

  • 14. Decreased levels of synaptosomal associated protein 25 in the brain of patients with Down syndrome and Alzheimer's disease.
    Greber S, Lubec G, Cairns N, Fountoulakis M.
    Electrophoresis; 1999 Jan 02; 20(4-5):928-34. PubMed ID: 10344268
    [Abstract] [Full Text] [Related]

  • 15. The reduction of NADH ubiquinone oxidoreductase 24- and 75-kDa subunits in brains of patients with Down syndrome and Alzheimer's disease.
    Kim SH, Vlkolinsky R, Cairns N, Fountoulakis M, Lubec G.
    Life Sci; 2001 May 04; 68(24):2741-50. PubMed ID: 11400916
    [Abstract] [Full Text] [Related]

  • 16. SCG10, a neuron-specific growth-associated protein in Alzheimer's disease.
    Okazaki T, Wang H, Masliah E, Cao M, Johnson SA, Sundsmo M, Saitoh T, Mori N.
    Neurobiol Aging; 1995 May 04; 16(6):883-94. PubMed ID: 8622778
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Characterization of rat brain stathmin isoforms by two-dimensional gel electrophoresis-matrix assisted laser desorption/ionization and electrospray ionization-ion trap mass spectrometry.
    Zugaro LM, Reid GE, Ji H, Eddes JS, Murphy AC, Burgess AW, Simpson RJ.
    Electrophoresis; 1998 May 04; 19(5):867-76. PubMed ID: 9629929
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Differential expression of molecular chaperones in brain of patients with Down syndrome.
    Yoo BC, Vlkolinsky R, Engidawork E, Cairns N, Fountoulakis M, Lubec G.
    Electrophoresis; 2001 Apr 04; 22(6):1233-41. PubMed ID: 11358150
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.